Treatment of psoriasis. Part 2. Systemic therapies

Journal of the American Academy of Dermatology
M Lebwohl, S Ali

Abstract

The array of systemic medications used in the treatment of psoriasis is rapidly expanding. In the United States, methotrexate, retinoids, and cyclosporine are the only systemic drugs approved by the Food and Drug Administration for the treatment of psoriasis. Monitoring and dosage recommendations for these medications are reviewed. Other drugs that are currently available include tacrolimus, mycophenolate mofetil, hydroxyurea, 6-thioguanine, and sulfasalazine. Experience with these drugs is summarized, and dosage and monitoring recommendations in published literature are presented. Combinations of different treatments are addressed and investigational therapies that are in development are reviewed.

Citations

Aug 15, 2003·The New England Journal of Medicine·Vera M R HeydendaelMenno A de Rie
Feb 15, 2005·Annals of the Rheumatic Diseases·M LebwohlJ Y M Koo
Feb 6, 2008·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Claudia HernandezJune K Robinson
Apr 4, 2015·Expert Review of Clinical Immunology·Aurélie ReinhardLaurent Peyrin-Biroulet
Jul 2, 2005·Expert Opinion on Emerging Drugs·Robert Gniadecki, Martin J Calverley
Feb 13, 2016·Pediatric Dermatology·Daniel M KlufasBruce E Strober
Jul 9, 2011·Expert Opinion on Pharmacotherapy·Jonathan P StaidleSteven R Feldman
Apr 17, 2002·Expert Opinion on Biological Therapy·Gerald G Krueger
Mar 1, 2006·Expert Opinion on Investigational Drugs·Felix Braun, Matthias Behrend
Feb 11, 2005·Current Medical Research and Opinion·William H CrownCraig Leonardi
Apr 6, 2013·Dermatologic Clinics·Ann L Marqueling, Kelly M Cordoro
May 1, 2010·Seminars in Cutaneous Medicine and Surgery·Natalie A WrightLawrence F Eichenfield
Jan 1, 2008·Advances in Dermatology·Kelly M Cordoro
May 22, 2009·The Journal of Investigative Dermatology·Joel M GelfandAndrea B Troxel
Aug 30, 2008·Clinics in Dermatology·Caroline P Halverstam, Mark Lebwohl
Apr 2, 2008·Journal of the American Academy of Dermatology·Vaishali PatelMark Lebwohl
May 5, 2005·International Journal of Dermatology·Ernest LeeTim Berger
Dec 20, 2005·The Journal of Dermatology·Mariko SeishimaShinya Yamanaka
Sep 24, 2004·Dermatologic Therapy·Menno A de RieJan D Bos
Sep 24, 2004·Dermatologic Therapy·Debra Lewkowicz, Alice B Gottlieb
Jul 14, 2006·Journal of the European Academy of Dermatology and Venereology : JEADV·J PedrazA García-Díez
Aug 3, 2006·Journal of Clinical Pharmacy and Therapeutics·A Damasiewicz-BodzekB Suwała-Jurczyk
Sep 25, 2008·Photodermatology, Photoimmunology & Photomedicine·Yasmeen K TandonElma D Baron
Jan 10, 2008·Journal of the European Academy of Dermatology and Venereology : JEADV·S C CarneiroM Ramos-e-Silva
Apr 17, 2008·International Journal of Dermatology·Elizabeth C A SmithMark Lebwohl
Apr 20, 2012·The British Journal of Dermatology·E A W WolberinkM J P Gerritsen
Sep 28, 2010·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Silja Domm, Ulrich Mrowietz
Jan 1, 2005·Journal of the American Academy of Dermatology·Amit S KulkarniSteven R Feldman
Nov 4, 2004·Journal of the American Academy of Dermatology·Joel M GelfandDavid J Margolis
Jun 22, 2005·Journal of the American Academy of Dermatology·Alice B Gottlieb
Jun 21, 2005·Journal of the American Academy of Dermatology·Steven R FeldmanJerry Bagel
Jun 21, 2005·Journal of the American Academy of Dermatology·Arun P VenkatSteven R Feldman
Apr 18, 2016·Dermatology and Therapy·Maddalena NapolitanoNicola Balato
Jan 31, 2013·Journal of the American Academy of Dermatology·Alice J WatsonRobert Swerlick
Aug 2, 2003·Journal of the American Academy of Dermatology·Paul S YamauchiNicholas J Lowe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.